95 related articles for article (PubMed ID: 19799805)
1. [Highlights of 2009 Kunming symposium on nasopharyngeal carcinoma].
Gan KJ; Xia YF
Ai Zheng; 2009 Oct; 28(10):1009-11. PubMed ID: 19799805
[No Abstract] [Full Text] [Related]
2. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
3. Pre-malignant nasopharyngeal epithelial cell models.
Kong QL; Guan S; Guo BH; Zeng MS
Ai Zheng; 2009 Oct; 28(10):1012-5. PubMed ID: 19799806
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma: a review.
Petersson F
Semin Diagn Pathol; 2015 Jan; 32(1):54-73. PubMed ID: 25769204
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr-virus infection and persistence: a B-cell marriage in sickness and in health.
Young LS
Lancet; 1999 Oct; 354(9185):1141-2. PubMed ID: 10513704
[No Abstract] [Full Text] [Related]
6. [NK/T-Cell lymphoma of nasopharynx].
Mani R; Belcadhi M; Krifa N; Sriha B; Elomri H; Ben Ali M; Abdelkéfi M; Bouzouita K
Ann Otolaryngol Chir Cervicofac; 2006 Sep; 123(4):189-93. PubMed ID: 17088706
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
8. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
9. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
[TBL] [Abstract][Full Text] [Related]
10. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma.
Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K
Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817
[TBL] [Abstract][Full Text] [Related]
11. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
12. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi J; Fouda A; Fossi A; Bejanga B
Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
14. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.
Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS
N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus latent membrane protein 1 induces the telomerase activity in human nasopharyngeal epithelial cells].
Yang J; Deng XY; Gu HH; Xia LQ; Yi W; Cao Y
Shi Yan Sheng Wu Xue Bao; 2001 Sep; 34(3):207-11. PubMed ID: 12549222
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.
Ma BB; Chan AT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Epstein-Barr virus BamH I "f" variant in nodal metastasis of nasopharyngeal carcinoma].
Liu QY; Han AJ; Yang QX; Dong Y; Wu JH; You SY; Li MF
Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):160-4. PubMed ID: 18788591
[TBL] [Abstract][Full Text] [Related]
18. [EBV and nasopharyngeal carcinoma].
Wakisaka N; Furukawa M
Nihon Rinsho; 2006 Mar; 64 Suppl 3():647-50. PubMed ID: 16615552
[No Abstract] [Full Text] [Related]
19. Nasopharyngeal nonkeratinizing (undifferentiated) monstrous cell carcinoma. A case report.
Avci A; Günhan O; Karslioğlu Y; Celasun B
Anal Quant Cytol Histol; 2011 Oct; 33(5):297-302. PubMed ID: 22611758
[TBL] [Abstract][Full Text] [Related]
20. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
